Literature DB >> 22537361

Medicaid expenditures on psychotropic medications for children in the child welfare system.

Ramesh Raghavan1, Derek S Brown, Hope Thompson, Susan L Ettner, Lisa M Clements, Whitney Key.   

Abstract

OBJECTIVE: Children in the child welfare system are the most expensive child population to insure for their mental health needs. The objective of this article is to estimate the amount of Medicaid expenditures incurred from the purchase of psychotropic drugs - the primary drivers of mental health expenditures - for these children.
METHODS: We linked a subsample of children interviewed in the first nationally representative survey of children coming into contact with U.S. child welfare agencies, the National Survey of Child and Adolescent Well-Being (NSCAW), to their Medicaid claims files obtained from the Medicaid Analytic Extract. Our data consist of children living in 14 states, and Medicaid claims for 4 years, adjusted to 2010 dollars. We compared expenditures on psychotropic medications in the NSCAW sample to a propensity score-matched comparison sample obtained from Medicaid files.
RESULTS: Children surveyed in NSCAW had over thrice the odds of any psychotropic drug use than the comparison sample. Each maltreated child increased Medicaid expenditures by between $237 and $840 per year, relative to comparison children also receiving medications. Increased expenditures on antidepressants and amphetamine-like stimulants were the primary drivers of these increased expenditures. On average, an African American child in NSCAW received $399 less expenditure than a white child, controlling for behavioral problems and other child and regional characteristics. Children scoring in the clinical range of the Child Behavior Checklist received, on average, $853 increased expenditure on psychotropic drugs.
CONCLUSION: Each child with child welfare involvement is likely to incur upwards of $1482 in psychotropic medication expenditures throughout his or her enrollment in Medicaid. Medicaid agencies should focus their cost-containment strategies on antidepressants and amphetamine-type stimulants, and expand use of instruments such as the Child Behavior Checklist to identify high-cost children. Both of these strategies can assist Medicaid agencies to better predict and plan for these expenditures.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22537361      PMCID: PMC3373221          DOI: 10.1089/cap.2011.0135

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  24 in total

1.  Help-seeking steps and service use for children in foster care.

Authors:  B T Zima; R Bussing; X Yang; T R Belin
Journal:  J Behav Health Serv Res       Date:  2000-08       Impact factor: 1.505

2.  Generalized modeling approaches to risk adjustment of skewed outcomes data.

Authors:  Willard G Manning; Anirban Basu; John Mullahy
Journal:  J Health Econ       Date:  2005-05       Impact factor: 3.883

3.  Studying prescription drug use and outcomes with medicaid claims data: strengths, limitations, and strategies.

Authors:  Stephen Crystal; Ayse Akincigil; Scott Bilder; James T Walkup
Journal:  Med Care       Date:  2007-10       Impact factor: 2.983

4.  Trends in mental health cost growth: an expanded role for management?

Authors:  Richard G Frank; Howard H Goldman; Thomas G McGuire
Journal:  Health Aff (Millwood)       Date:  2009 May-Jun       Impact factor: 6.301

5.  Using risk adjustment approaches in child welfare performance measurement: Applications and insights from health and mental health settings.

Authors:  Ramesh Raghavan
Journal:  Child Youth Serv Rev       Date:  2010-01-01

6.  Behavioral health service use and costs among children in foster care.

Authors:  Marion Becker; Neil Jordan; Rebecca Larsen
Journal:  Child Welfare       Date:  2006 May-Jun

7.  Contextual predictors of mental health service use among children open to child welfare.

Authors:  Michael S Hurlburt; Laurel K Leslie; John Landsverk; Richard P Barth; Barbara J Burns; Robert D Gibbons; Donald J Slymen; Jinjin Zhang
Journal:  Arch Gen Psychiatry       Date:  2004-12

8.  Measuring costs of child abuse and neglect: a mathematic model of specific cost estimations.

Authors:  Cynthia Conrad
Journal:  J Health Hum Serv Adm       Date:  2006

9.  Interstate variations in psychotropic medication use among a national sample of children in the child welfare system.

Authors:  Ramesh Raghavan; Gyanesh Lama; Patricia Kohl; Barton Hamilton
Journal:  Child Maltreat       Date:  2010-05

10.  A preliminary analysis of the receipt of mental health services consistent with national standards among children in the child welfare system.

Authors:  Ramesh Raghavan; Megumi Inoue; Susan L Ettner; Barton H Hamilton; John Landsverk
Journal:  Am J Public Health       Date:  2009-07-16       Impact factor: 9.308

View more
  7 in total

1.  Challenges in using medicaid claims to ascertain child maltreatment.

Authors:  Ramesh Raghavan; Derek S Brown; Benjamin T Allaire; Lauren D Garfield; Raven E Ross; Donald Hedeker
Journal:  Child Maltreat       Date:  2014-08-26

2.  Differences in ADHD medication usage patterns in children and adolescents from different cultural backgrounds in the Netherlands.

Authors:  Els F van den Ban; Patrick C Souverein; Herman van Engeland; Hanna Swaab; Toine C G Egberts; Eibert R Heerdink
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-05-28       Impact factor: 4.328

3.  Psychotropic drug use among preschool children in the Medicaid program from 36 states.

Authors:  Lauren D Garfield; Derek S Brown; Benjamin T Allaire; Raven E Ross; Ginger E Nicol; Ramesh Raghavan
Journal:  Am J Public Health       Date:  2015-01-20       Impact factor: 9.308

4.  Medicaid expenditures on psychotropic medications for maltreated children: a study of 36 States.

Authors:  Ramesh Raghavan; Derek S Brown; Benjamin T Allaire; Lauren D Garfield; Raven E Ross
Journal:  Psychiatr Serv       Date:  2014-11-17       Impact factor: 3.084

5.  Racial/ethnic differences in Medicaid expenditures on psychotropic medications among maltreated children.

Authors:  Ramesh Raghavan; Derek S Brown; Benjamin T Allaire; Lauren D Garfield; Raven E Ross; Lonnie R Snowden
Journal:  Child Abuse Negl       Date:  2014-03-16

6.  Research using population-based administration data integrated with longitudinal data in child protection settings: A systematic review.

Authors:  Fadzai Chikwava; Reinie Cordier; Anna Ferrante; Melissa O'Donnell; Renée Speyer; Lauren Parsons
Journal:  PLoS One       Date:  2021-03-24       Impact factor: 3.240

7.  Rise, and pronounced regional variation, in methylphenidate, amphetamine, and lisdexamfetamine distribution in the United States.

Authors:  Sneha M Vaddadi; Nicholas J Czelatka; Belsy D Gutierrez; Bhumika C Maddineni; Kenneth L McCall; Brian J Piper
Journal:  PeerJ       Date:  2021-12-21       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.